Chemoinformaics analysis of 10,12-Hexadecadien-1-ol
Molecular Weight | 238.415 | nRot | 12 |
Heavy Atom Molecular Weight | 208.175 | nRig | 2 |
Exact Molecular Weight | 238.23 | nRing | 0 |
Solubility: LogS | -5.188 | nHRing | 0 |
Solubility: LogP | 5.81 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 47.5258 |
nHD | 1 | BPOL | 30.0962 |
QED | 0.374 |
Synth | 2.422 |
Natural Product Likeliness | 1.358 |
NR-PPAR-gamma | 0.014 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.135 |
Pgp-sub | 0.122 |
HIA | 0.004 |
CACO-2 | -4.571 |
MDCK | 0.0000172 |
BBB | 0.511 |
PPB | 0.969627 |
VDSS | 2.781 |
FU | 0.0220801 |
CYP1A2-inh | 0.826 |
CYP1A2-sub | 0.42 |
CYP2c19-inh | 0.402 |
CYP2c19-sub | 0.283 |
CYP2c9-inh | 0.218 |
CYP2c9-sub | 0.922 |
CYP2d6-inh | 0.097 |
CYP2d6-sub | 0.57 |
CYP3a4-inh | 0.489 |
CYP3a4-sub | 0.121 |
CL | 5.393 |
T12 | 0.366 |
hERG | 0.113 |
Ames | 0.018 |
ROA | 0.134 |
SkinSen | 0.985 |
Carcinogencity | 0.196 |
EI | 0.958 |
Respiratory | 0.968 |
NR-Aromatase | 0.752 |
Antiviral | Yes |
Prediction | 0.743527 |